Chongqing Taiji Industry Group Co Ltd - Asset Resilience Ratio
Chongqing Taiji Industry Group Co Ltd (600129) has an Asset Resilience Ratio of 0.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600129 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1994–2024)
This chart shows how Chongqing Taiji Industry Group Co Ltd's Asset Resilience Ratio has changed over time. See 600129 book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Chongqing Taiji Industry Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600129 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥122.54 Million | 0.86% |
| Total Liquid Assets | CN¥122.54 Million | 0.86% |
Asset Resilience Insights
- Limited Liquidity: Chongqing Taiji Industry Group Co Ltd maintains only 0.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Chongqing Taiji Industry Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Chongqing Taiji Industry Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
Drug Manufacturers - Specialty & Generic | 43.05% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277 |
Drug Manufacturers - Specialty & Generic | 31.63% |
|
Hainan Shuangcheng Pharmaceut
SHE:002693 |
Drug Manufacturers - Specialty & Generic | 3.29% |
Annual Asset Resilience Ratio for Chongqing Taiji Industry Group Co Ltd (1994–2024)
The table below shows the annual Asset Resilience Ratio data for Chongqing Taiji Industry Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.01% | CN¥141.49 Million ≈ $20.70 Million |
CN¥14.06 Billion ≈ $2.06 Billion |
-0.14pp |
| 2023-12-31 | 1.15% | CN¥165.87 Million ≈ $24.27 Million |
CN¥14.41 Billion ≈ $2.11 Billion |
-0.58pp |
| 2022-12-31 | 1.74% | CN¥255.24 Million ≈ $37.35 Million |
CN¥14.71 Billion ≈ $2.15 Billion |
-1.37pp |
| 2021-12-31 | 3.10% | CN¥408.87 Million ≈ $59.83 Million |
CN¥13.17 Billion ≈ $1.93 Billion |
+1.04pp |
| 2020-12-31 | 2.06% | CN¥298.60 Million ≈ $43.69 Million |
CN¥14.49 Billion ≈ $2.12 Billion |
-1.77pp |
| 2019-12-31 | 3.83% | CN¥543.39 Million ≈ $79.51 Million |
CN¥14.19 Billion ≈ $2.08 Billion |
+1.50pp |
| 2018-12-31 | 2.33% | CN¥300.00 Million ≈ $43.90 Million |
CN¥12.89 Billion ≈ $1.89 Billion |
+2.17pp |
| 2014-12-31 | 0.16% | CN¥16.53 Million ≈ $2.42 Million |
CN¥10.35 Billion ≈ $1.51 Billion |
+0.16pp |
| 2006-12-31 | 0.00% | CN¥200.00K ≈ $29.27K |
CN¥5.78 Billion ≈ $845.06 Million |
-0.05pp |
| 2003-12-31 | 0.05% | CN¥1.99 Million ≈ $290.78K |
CN¥3.94 Billion ≈ $577.15 Million |
0.00pp |
| 2002-12-31 | 0.06% | CN¥1.76 Million ≈ $257.30K |
CN¥3.20 Billion ≈ $467.62 Million |
+0.05pp |
| 2001-12-31 | 0.00% | CN¥5.00K ≈ $731.66 |
CN¥2.73 Billion ≈ $399.81 Million |
-0.12pp |
| 1998-12-31 | 0.12% | CN¥2.00 Million ≈ $292.66K |
CN¥1.61 Billion ≈ $235.04 Million |
+0.12pp |
| 1996-12-31 | 0.00% | CN¥1.70K ≈ $248.76 |
CN¥560.77 Million ≈ $82.06 Million |
-0.01pp |
| 1995-12-31 | 0.01% | CN¥20.94K ≈ $3.06K |
CN¥280.22 Million ≈ $41.01 Million |
-0.01pp |
| 1994-12-31 | 0.02% | CN¥21.87K ≈ $3.20K |
CN¥132.54 Million ≈ $19.39 Million |
-- |
About Chongqing Taiji Industry Group Co Ltd
Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, produces, and sells Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Commercial; Chinese Herbal Medicine Resources; and Service Industry and Others segments. The company offers digestive system and metabolic, respiratory system, cardiovascular and… Read more